Cargando…
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
Type 2 diabetes mellitus is a worldwide epidemic with considerable health and economic consequences. Diabetes is an important risk factor for cardiovascular disease, which is the leading cause of death in diabetic patients, and decreasing the incidence of diabetes may potentially reduce the burden o...
Autor principal: | Basile, J N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705820/ https://www.ncbi.nlm.nih.gov/pubmed/19220522 http://dx.doi.org/10.1111/j.1742-1241.2009.02009.x |
Ejemplares similares
-
New-onset diabetes and antihypertensive treatment
por: Grimm, Christine, et al.
Publicado: (2010) -
Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020) -
Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019) -
Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023) -
A Retrospective Longitudinal Cohort Study of Antihypertensive Drug Use and New-Onset Diabetes in Taiwanese Patients
por: Huang, Ching-Ya, et al.
Publicado: (2013)